
|Articles|March 15, 2021
What's new on Contemporary Pediatrics: March 15 to March 19
A look at what to expect from Contemporary Pediatrics this week
Advertisement
Multisystem inflammatory syndrome in children can present it a number of ways. A recent investigations if certain demographic and clinical characteristics could indicate a potential risk for severe outcomes.
The treatment options for sickle cell disease have led to improved outcomes. We’ll offer a look at the current treatment options, as well as some recent pediatric oncology approvals.
Plus, a look at umbilical cord management with preterm infants and its impact on outcomes.
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves risankizumab for pediatric plaque psoriasis and psoriatic arthritis
2
FDA fast tracks BM-3103 gel for epidermolysis bullosa simplex
3
FDA updates in pediatric care: Q2 2026 recap
4
5 FDA decisions to watch for during 2H 2026
5


